What is Windtree Therapeutics?
Founded in 1992, Windtree Therapeutics operates as a specialty biotechnology entity dedicated to the advancement of respiratory critical care. The company is distinguished by its proprietary KL4 surfactant technology, a platform designed to treat severe respiratory conditions where traditional interventions often fall short. By integrating advanced aerosolizing respiratory delivery medicines, Windtree addresses complex clinical challenges, positioning itself as a vital player in the critical care ecosystem. The firm's market position is defined by its long-standing commitment to scientific rigor and the development of high-impact medical technologies that serve both hospital and acute care settings.
How much funding has Windtree Therapeutics raised?
Windtree Therapeutics has raised a total of $512.9M across 2 funding rounds:
Debt
$12.9M
Debt
$500M
Debt (2024): $12.9M, investors not publicly disclosed
Debt (2025): $500M, investors not publicly disclosed
Key Investors in Windtree Therapeutics
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Windtree Therapeutics?
With the recent infusion of capital, Windtree Therapeutics is poised to transition into a more aggressive phase of clinical execution and commercial readiness. The strategic focus will likely shift toward optimizing the delivery mechanisms of its core surfactant assets and expanding the reach of its aerosolized medicine portfolio. As the company moves forward, the primary objective remains the successful navigation of regulatory milestones and the potential expansion of its therapeutic applications. This enterprise-level funding provides the stability required to pursue these high-value objectives, ultimately aiming to improve patient outcomes in critical care environments while delivering sustained value to stakeholders through continued innovation in respiratory health.
See full Windtree Therapeutics company page
